XML 186 R90.htm IDEA: XBRL DOCUMENT v3.25.1
Fair value measurements - Narrative (Details)
12 Months Ended
Aug. 30, 2021
₪ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
shares
Aug. 30, 2021
$ / shares
shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Number of securities issued per warrant exercised (in shares) 1     1
Exercise price (USD per share) | (per share) ₪ 11.50     $ 0.1
Days after completion of transaction in which award is exercisable 30 days      
Expiration period 5 years      
Price per share, company redemption option (USD per share) | ₪ / shares ₪ 0.01      
Minimum share price of company stock, in which company can redeem warrants (USD per share) | ₪ / shares ₪ 18.00      
Trading days within a 30-trading day period 20 days      
Trading day period 30 days      
Warrants and Rights Outstanding | $   $ 11    
Restricted stock        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Number of shares (in shares)     7,500,000  
Ordinary shares and vested restricted stock units        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Number of shares (in shares)   15,000,000 15,000,000  
The Sponsor | TWC Tech Holdings II Corp. (“TWC")        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Number of shares (in shares)   13,500,000    
The Sponsor | Restricted stock | TWC Tech Holdings II Corp. (“TWC")        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Number of shares (in shares)   7,500,000    
Contingent consideration threshold trading days   20 days    
Contingent consideration threshold consecutive trading days   30 days    
Contingent consideration price adjustment expiration period   7 years    
The Sponsor | Restricted stock | TWC Tech Holdings II Corp. (“TWC") | Reverse recapitalization agreement, tranche one        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Number of shares (in shares)   3,000,000    
Contingent consideration terms, stock price trigger (in USD per share) | $ / shares   $ 12.50    
The Sponsor | Restricted stock | TWC Tech Holdings II Corp. (“TWC") | Reverse recapitalization agreement, tranche two        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Number of shares (in shares)   3,000,000    
Contingent consideration terms, stock price trigger (in USD per share) | $ / shares   $ 15.00    
The Sponsor | Restricted stock | TWC Tech Holdings II Corp. (“TWC") | Reverse recapitalization agreement, tranche three        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Number of shares (in shares)   1,500,000    
Contingent consideration terms, stock price trigger (in USD per share) | $ / shares   $ 30.00    
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units | Ordinary shares and vested restricted stock units | TWC Tech Holdings II Corp. (“TWC")        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Number of shares (in shares)   15,000,000    
Contingent consideration threshold trading days   20 days    
Contingent consideration threshold consecutive trading days   30 days    
Contingent consideration terms, performance period   5 years    
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units | Ordinary shares and vested restricted stock units | TWC Tech Holdings II Corp. (“TWC") | Reverse recapitalization agreement, tranche one        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Number of shares (in shares)   5,000,000    
Contingent consideration terms, stock price trigger (in USD per share) | $ / shares   $ 12.5    
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units | Ordinary shares and vested restricted stock units | TWC Tech Holdings II Corp. (“TWC") | Reverse recapitalization agreement, tranche two        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Number of shares (in shares)   5,000,000    
Contingent consideration terms, stock price trigger (in USD per share) | $ / shares   $ 15    
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units | Ordinary shares and vested restricted stock units | TWC Tech Holdings II Corp. (“TWC") | Reverse recapitalization agreement, tranche three        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Number of shares (in shares)   5,000,000    
Contingent consideration terms, stock price trigger (in USD per share) | $ / shares   $ 17.5    
Public Warrant Liability        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Class of warrant or right, outstanding (in shares) 20,000,000 19,878,580 19,999,449 20,000,000
Exercise price (USD per share) | $ / shares   $ 11.5    
Exercise of public warrants (in shares)   6,803,085    
Private Placement Warrants        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Class of warrant or right, outstanding (in shares) 9,666,667     9,666,667
Exercise of public warrants (in shares)   3,306,000    
Private Placement Warrants | Level 3        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Class of warrant or right, outstanding (in shares)   0 9,666,667  
Derivative liability, measurement input   0    
Share Settlement        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Exercise of public warrants (in shares)   6,798,440    
cash exercise [Member]        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Class of warrant or right, outstanding (in shares)   4,645    
Exercise of public warrants (in shares)   4,645    
Warrant Redemption        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Class of warrant or right, outstanding (in shares)   116,224